Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People between the ages of 18 and 70 years old (inclusive).
- People who have symptoms that may be related to diabetes — such as unusual thirst, increased hunger, frequent urination, or unexplained weight loss — and whose doctor has recommended a glucose tolerance test (a test where blood sugar is measured after drinking a sugary drink) to investigate further.
- People who have blood sugar or related test results that fall in an in-between range: a fasting blood glucose level between 6.1 and below 7.0 mmol/L, and/or a long-term blood sugar marker (HbA1c) between 5.7% and 6.4%.
- People who have at least one of the following risk factors for diabetes: a body weight category considered above the normal range (BMI of 24 or higher); a parent, brother, sister, or child who has been diagnosed with diabetes; or a personal history of high blood pressure or abnormal cholesterol/fat levels in the blood (or currently being treated for either of these conditions).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have already been diagnosed with diabetes.
- People who have recently taken certain medications that can affect blood sugar levels or gut hormones — such as GLP-1 receptor agonists, DPP-4 inhibitors, or steroid medications — within a specific period before joining the trial (confirm with trial site for exact timeframes).
- People who have had surgery on the stomach or intestines (such as removal of part of the stomach) or who have a long-term pancreatic condition.
- People with serious liver or kidney problems — for example, liver enzyme levels more than three times the normal upper limit, or kidney function below a certain level (confirm with trial site).
- Women who are pregnant, currently breastfeeding, or planning to become pregnant during the study.
- People with a known allergy to soy, as the test meal used in the study may contain soy-based ingredients.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jian Zhou, Shanghai Sixth People's Hospital, Shanghai, Shanghai 200233
Phone: +86 021 24056515
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Correlation between MMTT-induced glucose AUC and OGTT plasma glucose values
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.